PO152 | A CASE REPORT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA WITH PULMONARY ARTERIOVENOUS FISTULA
Abstract
Background. Hereditary hemorrhagic telangiectasia (HHT), is an autosomal dominant vascular disorder characterized by heterogeneous clinical expression (recurrent epistaxis, gastrointestinal bleeding, iron deficiency anemia, mucocutaneous telangiectasia and visceral arteriovenous malformations involving the pulmonary, hepatic, and cerebral circulations). Clinical diagnosis is based on established criteria, including epistaxis, characteristic telangiectasias, visceral arteriovenous malformations (AVMs) and a positive family history. Confirmation can be achieved through molecular testing identifying genetic variants (ACVRL1, ENG, SMAD4). Management includes local and systemic approaches to control bleeding, correction of anemia, embolization of AVMs, and the use of antifibrinolytic or anti-angiogenic therapies. Case Reports. A 57-year-old woman presented to the Emergency Department with dyspnea, severe hypoxemia (arterial pO2 60 mmHg) and anemia. Medical history included recurrent epistaxis and iron deficiency anemia. Contrast enhanced chest CT showed two large vascular lesions in the right lower lobe, consistent with arteriovenous malformations. The underwent successful embolization of the AVMs. Given the suspicion of HHT, otolaryngologic evaluation revealed small capillary ectasias in the right nasal cavity and mild varicose ectasias at the base of the tongue. Abdominal ultrasound demonstrated hepatic AVMs in the right lobe while brain MRI excluded cerebral involvement. Genetic testing (heterozygous variant in the ACVRL1 gene) confirmed the diagnosis of HHT. After one year of follow-up, the patient is asymptomatic for dyspnea with normal arterial pO2. Conclusions. HHT is a diagnostic challenge due to often underrecognized early symptoms, highly variable clinical expression ranging from mild to severe disease and silent vascular malformations. In our case, embolization of pulmonary AVMs has been completely successful. HHT requires multidisciplinary management, appropriate treatment and has a relevant familial impact due to its autosomal dominant inheritance, making family screening essential.
Related
- Delayed Renal Artery Stump Pseudoaneurysm and Arteriovenous Fistula Following Nephrectomy Complicated by Pulmonary Coil Migration: Successful Laparoscopic Management
- Modifiable Cardiovascular Risk Factors and Hemorrhagic Presentation in Dural Arteriovenous Fistulas: A Systematic Review With Exploratory Quantitative Synthesis
- Combined antegrade and retrograde transarterial approaches for embolization of a traumatic carotid‑cavernous fistula with concomitant middle meningeal arteriovenous fistula
- Progress on the related mechanisms of vascular calcification in autogenous arteriovenous fistula in hemodialysis patients
- A single-center before-and-after study of physiology-first algorithmic surveillance versus standard observation for arteriovenous fistula maturation
BibTeX
@article{veneri2026po152,
title = {{PO152 | A CASE REPORT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA WITH PULMONARY ARTERIOVENOUS FISTULA}},
author = {Mariangela Veneri},
journal = {Bleeding, Thrombosis and Vascular Biology},
year = {2026},
month = oct,
url = {https://www.btvb.org/btvb/article/view/968},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - PO152 | A CASE REPORT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA WITH PULMONARY ARTERIOVENOUS FISTULA
AU - Mariangela Veneri
PY - 2026
DA - 2026/10/26
JO - Bleeding, Thrombosis and Vascular Biology
UR - https://www.btvb.org/btvb/article/view/968
AB - Background. Hereditary hemorrhagic telangiectasia (HHT), is an autosomal dominant vascular disorder characterized by heterogeneous clinical expression (recurrent epistaxis, gastrointestinal bleeding, iron deficiency anemia, mucocutaneous telangiectasia and visceral arteriovenous malformations involving the pulmonary, hepatic, and cerebral circulations). Clinical diagnosis is based on established criteria, including epistaxis, characteristic telangiectasias, visceral arteriovenous malformations (AVMs) and a positive family history. Confirmation can be achieved through molecular testing identifying genetic variants (ACVRL1, ENG, SMAD4). Management includes local and systemic approaches to control bleeding, correction of anemia, embolization of AVMs, and the use of antifibrinolytic or anti-angiogenic therapies. Case Reports. A 57-year-old woman presented to the Emergency Department with dyspnea, severe hypoxemia (arterial pO2 60 mmHg) and anemia. Medical history included recurrent epistaxis and iron deficiency anemia. Contrast enhanced chest CT showed two large vascular lesions in the right lower lobe, consistent with arteriovenous malformations. The underwent successful embolization of the AVMs. Given the suspicion of HHT, otolaryngologic evaluation revealed small capillary ectasias in the right nasal cavity and mild varicose ectasias at the base of the tongue. Abdominal ultrasound demonstrated hepatic AVMs in the right lobe while brain MRI excluded cerebral involvement. Genetic testing (heterozygous variant in the ACVRL1 gene) confirmed the diagnosis of HHT. After one year of follow-up, the patient is asymptomatic for dyspnea with normal arterial pO2. Conclusions. HHT is a diagnostic challenge due to often underrecognized early symptoms, highly variable clinical expression ranging from mild to severe disease and silent vascular malformations. In our case, embolization of pulmonary AVMs has been completely successful. HHT requires multidisciplinary management, appropriate treatment and has a relevant familial impact due to its autosomal dominant inheritance, making family screening essential.
SN - 2785-5309
ER -